FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2601024043> ?p ?o ?g. }

• W2601024043 endingPage "651" @default.
• W2601024043 startingPage "640" @default.
• W2601024043 abstract "Objectives: Sudden and severe onset of obsessive–compulsive disorder (OCD) may present secondary to infectious and/or immune-mediated triggers. We assessed the preliminary efficacy, tolerability, and safety of azithromycin compared with placebo in the treatment of OCD and associated symptoms in children with pediatric acute-onset neuropsychiatric syndrome (PANS). Methods: Thirty-one youth aged 4–14 years (M = 8.26 ± 2.78 years, 62.5% male) were randomized to receive either placebo or azithromycin for 4 weeks (10 mg/kg up to 500 mg per day). Both groups were administered twice daily probiotics. The primary outcome, obsessive–compulsive symptom severity, was assessed using the OCD Clinical Global Impressions Severity (CGI-S OCD) and Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS). Results: Participants in the azithromycin group (n = 17) showed significantly greater reductions in OCD severity on the CGI-S OCD than the placebo group (n = 14) posttreatment (p = 0.003), although there were no significant differences on the CY-BOCS. Significantly more participants in the azithromycin condition met treatment responder criteria on the CGI-I OCD at the end of week 4 (41.2%, n = 7) in comparison to the placebo group (7.1%, n = 1; p = 0.045). Tic severity moderated treatment response, with greater tic severity being associated with enhanced treatment response on the CGI-S OCD. Azithromycin was well tolerated with minimal adverse effects and no study dropouts due to side effects. However, the azithromycin group showed a trend toward significantly greater electrocardiography QTc (p = 0.060) at the end of week 4, and significantly more reports of loose or abnormal stools (p = 0.009). Conclusion: This double blind pilot study suggests that azithromycin may be helpful in treating youth meeting the PANS diagnosis, especially those with elevated levels of both OCD and tic symptoms. Azithromycin was well tolerated, but the potential for cardiac risks suggests that additional monitoring may be needed to ensure safety." @default.
• W2601024043 created "2017-04-07" @default.
• W2601024043 creator A5010579236 @default.
• W2601024043 creator A5037100218 @default.
• W2601024043 creator A5043972700 @default.
• W2601024043 creator A5049652314 @default.
• W2601024043 creator A5055252759 @default.
• W2601024043 creator A5065218951 @default.
• W2601024043 creator A5089897759 @default.
• W2601024043 date "2017-09-01" @default.
• W2601024043 modified "2023-10-12" @default.
• W2601024043 title "A Double-Blind Randomized Placebo-Controlled Pilot Study of Azithromycin in Youth with Acute-Onset Obsessive–Compulsive Disorder" @default.
• W2601024043 cites W1227660288 @default.
• W2601024043 cites W1881340643 @default.
• W2601024043 cites W1920510593 @default.
• W2601024043 cites W1946691801 @default.
• W2601024043 cites W1972859381 @default.
• W2601024043 cites W1974498819 @default.
• W2601024043 cites W1975482790 @default.
• W2601024043 cites W1990682046 @default.
• W2601024043 cites W1998585277 @default.
• W2601024043 cites W1999279024 @default.
• W2601024043 cites W2012458918 @default.
• W2601024043 cites W2012943713 @default.
• W2601024043 cites W2013009597 @default.
• W2601024043 cites W2019101336 @default.
• W2601024043 cites W2025586896 @default.
• W2601024043 cites W2032404423 @default.
• W2601024043 cites W2039129759 @default.
• W2601024043 cites W2044740696 @default.
• W2601024043 cites W2046154378 @default.
• W2601024043 cites W2047290261 @default.
• W2601024043 cites W2048096554 @default.
• W2601024043 cites W2050000178 @default.
• W2601024043 cites W2050647926 @default.
• W2601024043 cites W2057799337 @default.
• W2601024043 cites W2068195191 @default.
• W2601024043 cites W2068306013 @default.
• W2601024043 cites W2069390699 @default.
• W2601024043 cites W2070176743 @default.
• W2601024043 cites W2076027411 @default.
• W2601024043 cites W2077615819 @default.
• W2601024043 cites W2079689365 @default.
• W2601024043 cites W2081841619 @default.
• W2601024043 cites W2092805498 @default.
• W2601024043 cites W2096667163 @default.
• W2601024043 cites W2111453841 @default.
• W2601024043 cites W2114776324 @default.
• W2601024043 cites W2122456510 @default.
• W2601024043 cites W2125658727 @default.
• W2601024043 cites W2133887970 @default.
• W2601024043 cites W2156107325 @default.
• W2601024043 cites W2165600894 @default.
• W2601024043 cites W2208060404 @default.
• W2601024043 cites W2271258058 @default.
• W2601024043 cites W4254230094 @default.
• W2601024043 cites W49920225 @default.
• W2601024043 doi "https://doi.org/10.1089/cap.2016.0190" @default.
• W2601024043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28358599" @default.
• W2601024043 hasPublicationYear "2017" @default.
• W2601024043 type Work @default.
• W2601024043 sameAs 2601024043 @default.
• W2601024043 citedByCount "36" @default.
• W2601024043 countsByYear W26010240432017 @default.
• W2601024043 countsByYear W26010240432018 @default.
• W2601024043 countsByYear W26010240432019 @default.
• W2601024043 countsByYear W26010240432020 @default.
• W2601024043 countsByYear W26010240432021 @default.
• W2601024043 countsByYear W26010240432022 @default.
• W2601024043 countsByYear W26010240432023 @default.
• W2601024043 crossrefType "journal-article" @default.
• W2601024043 hasAuthorship W2601024043A5010579236 @default.
• W2601024043 hasAuthorship W2601024043A5037100218 @default.
• W2601024043 hasAuthorship W2601024043A5043972700 @default.
• W2601024043 hasAuthorship W2601024043A5049652314 @default.
• W2601024043 hasAuthorship W2601024043A5055252759 @default.
• W2601024043 hasAuthorship W2601024043A5065218951 @default.
• W2601024043 hasAuthorship W2601024043A5089897759 @default.
• W2601024043 hasConcept C118552586 @default.
• W2601024043 hasConcept C126322002 @default.
• W2601024043 hasConcept C142724271 @default.
• W2601024043 hasConcept C15744967 @default.
• W2601024043 hasConcept C168563851 @default.
• W2601024043 hasConcept C197934379 @default.
• W2601024043 hasConcept C202061045 @default.
• W2601024043 hasConcept C204787440 @default.
• W2601024043 hasConcept C27081682 @default.
• W2601024043 hasConcept C2778375690 @default.
• W2601024043 hasConcept C2778907293 @default.
• W2601024043 hasConcept C2991744798 @default.
• W2601024043 hasConcept C30036603 @default.
• W2601024043 hasConcept C3017582312 @default.
• W2601024043 hasConcept C501593827 @default.
• W2601024043 hasConcept C71924100 @default.
• W2601024043 hasConcept C86803240 @default.
• W2601024043 hasConcept C89423630 @default.
• W2601024043 hasConceptScore W2601024043C118552586 @default.
• W2601024043 hasConceptScore W2601024043C126322002 @default.

• next